Immunohistochemistry Her-2 ErbB2 Breast Test sale cost 370 AED
Thyroglobulin Tg Test sale cost 400 AED Thyroglobulin Tg Test 440 د.إ Original price was: 440 د.إ.400 د.إCurrent price is: 400 د.إ.
Sale!

Immunohistochemistry Her-2 ErbB2 Breast Test

Original price was: 410 د.إ.Current price is: 370 د.إ.

-10%

The “Immunohistochemistry Her-2 ErbB2 Breast Test” is a diagnostic procedure used to evaluate the expression of the HER2 protein in breast cancer tissues. HER2, also known as ErbB2, is a protein that can promote the growth of cancer cells. In some cases, breast cancer cells produce an excess of HER2 due to a gene amplification. Identifying the status of HER2 in breast cancer is crucial as it helps in determining the prognosis and guiding targeted therapy decisions. HER2-positive cancers may be more aggressive but are often treatable with drugs specifically designed to target this protein.

This test involves the use of immunohistochemistry (IHC), a technique that utilizes antibodies to detect HER2 protein expression levels on the surface of cells in a tissue sample. The results are typically scored on a scale from 0 to 3+, with 0 and 1+ considered negative, 2+ borderline, and 3+ positive for HER2 protein overexpression.

In the UAE, DNA Labs offers this important test for patients diagnosed with breast cancer. The cost of the test at DNA Labs UAE is 370 AED. This facility ensures accurate and reliable testing, employing advanced technology and expert technicians to provide results that are crucial for the effective management and treatment of breast cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY HER-2 ERBB2 BREAST Test

Cost: AED 370.0

Test Name: IMMUNOHISTOCHEMISTRY HER-2 ERBB2 BREAST Test

Components: Price: 370.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Report Delivery: Sample Daily by 6 pm; Report Block: 5 days, Tissue Biopsy: 5 days, Tissue large complex: 7 days

Method: Immunohistochemistry

Test type: Cancer

Doctor: Oncologist, Pathologist

Test Department:

Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details

The IMMUNOHISTOCHEMISTRY HER-2/ERBB2 (BREAST) test is a diagnostic test used in breast cancer patients to determine the presence and level of the HER-2 protein in tumor cells. HER-2, also known as ERBB2, is a receptor protein that plays a role in cell growth and division.

This test involves the use of specific antibodies that bind to the HER-2 protein in breast cancer tissue samples. The antibodies are labeled with a visible marker, such as a fluorescent dye or an enzyme, which allows the detection of the protein in the tissue.

The results of the test are usually reported as a score based on the staining intensity and the percentage of tumor cells showing HER-2 protein expression. The scoring system ranges from 0 to 3+, with 0 or 1+ indicating low or no HER-2 expression, 2+ indicating equivocal expression, and 3+ indicating high expression.

The IMMUNOHISTOCHEMISTRY HER-2/ERBB2 test is important in determining the eligibility of breast cancer patients for targeted therapy with drugs like trastuzumab (Herceptin). High levels of HER-2 expression indicate a higher likelihood of response to these targeted therapies.

It is important to note that this test is typically performed on breast cancer tissue samples obtained through a biopsy or surgery. It is usually ordered by a pathologist or an oncologist as part of the diagnostic workup for breast cancer patients.

Test Name IMMUNOHISTOCHEMISTRY HER-2 ERBB2 BREAST Test
Components
Price 370.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist, Pathologist
Test Department:
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The IMMUNOHISTOCHEMISTRY HER-2/ERBB2 (BREAST) test is a diagnostic test used in breast cancer patients to determine the presence and level of the HER-2 protein in tumor cells. HER-2, also known as ERBB2, is a receptor protein that plays a role in cell growth and division.

This test involves the use of specific antibodies that bind to the HER-2 protein in breast cancer tissue samples. The antibodies are labeled with a visible marker, such as a fluorescent dye or an enzyme, which allows the detection of the protein in the tissue.

The results of the test are usually reported as a score based on the staining intensity and the percentage of tumor cells showing HER-2 protein expression. The scoring system ranges from 0 to 3+, with 0 or 1+ indicating low or no HER-2 expression, 2+ indicating equivocal expression, and 3+ indicating high expression.

The IMMUNOHISTOCHEMISTRY HER-2/ERBB2 test is important in determining the eligibility of breast cancer patients for targeted therapy with drugs like trastuzumab (Herceptin). High levels of HER-2 expression indicate a higher likelihood of response to these targeted therapies.

It is important to note that this test is typically performed on breast cancer tissue samples obtained through a biopsy or surgery. It is usually ordered by a pathologist or an oncologist as part of the diagnostic workup for breast cancer patients.

SKU: TEST-6575 Category:

Related products